AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

METOPROLOL SUCCINATE

30 registrations across 4 African markets— 30 active

Markets with METOPROLOL SUCCINATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
Betaloc Zok 50 mg Tablets
Prolonged-Release Tablet
🇰🇪KenyaAstraZeneca UK LimitedactiveJul 2031
Betaloc Zok 25 mg Tablets
Tablet
🇰🇪KenyaAstraZeneca UK LimitedactiveJul 2031
Betaloc ZOK 100 mg Tablets
Prolonged-Release Tablet
🇰🇪KenyaAstraZeneca UK LimitedactiveJul 2031
Revelol XL 50
Film-Coated Tablet
🇰🇪KenyaIpca Laboratories LimitedactiveJan 2031
BETALOC ZOK
TABLET, COATED; ORAL
🇿🇼ZimbabweASTRA ZENECA LIMITEDactiveApr 2030
BETALOC ZOK
TABLET; ORAL
🇿🇼ZimbabweASTRA ZENECA LIMITEDactiveApr 2030
BETALOC ZOK
TABLET, COATED; ORAL
🇿🇼ZimbabweASTRA ZENECA LIMITEDactiveApr 2030
REVELOL-XL-50
TABLET, COATED; ORAL
🇿🇼ZimbabweIPCA LABORATORIES LIMITEDactiveDec 2027
BETALOC ZOK 25🇬🇭GhanaASTRAZENECA UK LIMITED CHARTER WAY, MACCLESFIELD SK10 2NA, UNITED KINGDOMactiveDec 2026
BETALOC ZOK 100🇬🇭GhanaASTRAZENECA UK LIMITED CHARTER WAY, MACCLESFIELD SK10 2NA, UNITED KINGDOMactiveDec 2026
BETALOC ZOK 50🇬🇭GhanaASTRAZENECA UK LIMITED CHARTER WAY, MACCLESFIELD SK10 2NA, UNITED KINGDOMactiveDec 2026
BETALOC ZOK 50🇬🇭GhanaASTRAZENECA UK LIMITED CHARTER WAY, MACCLESFIELD SK10 2NA, UNITED KINGDOMactiveDec 2026
BETALOC ZOK 100🇬🇭GhanaASTRAZENECA UK LIMITED CHARTER WAY, MACCLESFIELD SK10 2NA, UNITED KINGDOMactiveDec 2026
BETALOC ZOK 25🇬🇭GhanaASTRAZENECA UK LIMITED CHARTER WAY, MACCLESFIELD SK10 2NA, UNITED KINGDOMactiveDec 2026
METOPROLOL SUCCINATE
ORAL SOLID RETARD TABLETS
🇺🇬UgandaAJANTA PHARMA LTDactive
METOPROLOL SUCCINATE
ORAL SOLID RETARD FILM- COATED TABLETS
🇺🇬UgandaAJANTA PHARMA LIMITEDactive
METOPROLOL SUCCINATE
ORAL SOLID RETARD TABLETS
🇺🇬UgandaNTICALS LTD.active
METOPROLOL SUCCINATE
ORAL SOLID RETARD TABLETS
🇺🇬UgandaAJANTA PHARMA LTDactive
METOPROLOL SUCCINATE
ORAL SOLID RETARD TABLETS
🇺🇬UgandaMEGA LIFESCIENCES PUBLIC COMPANY LTDactive
METOPROLOL SUCCINATE
ORAL SOLID RETARD TABLETS
🇺🇬UgandaAJANTA PHARMA LTDactive
METOPROLOL SUCCINATE
ORAL SOLID RETARD FILM-COATED TABLETS
🇺🇬UgandaAJANTA PHARMA LIMITEDactive
METOPROLOL SUCCINATE
ORAL SOLID RETARD TABLETS
🇺🇬UgandaNTICALS LTD.active
METOPROLOL SUCCINATE
ORAL SOLID RETARD FILM- COATED TABLETS
🇺🇬UgandaAJANTA PHARMA LIMITEDactive
METOPROLOL SUCCINATE
ORAL SOLID RETARD TABLETS
🇺🇬UgandaMEGA LIFESCIENCES PUBLIC COMPANY LTDactive
METOPROLOL SUCCINATE
ORAL SOLID RETARD TABLETS
🇺🇬UgandaAJANTA PHARMA LTDactive
METOPROLOL SUCCINATE
ORAL SOLID RETARD TABLETS
🇺🇬UgandaMEGA LIFESCIENCES PUBLIC COMPANY LTDactive
METOPROLOL SUCCINATE
ORAL SOLID RETARD TABLETS
🇺🇬UgandaNTICALS LTD.active
METOPROLOL SUCCINATE
ORAL SOLID RETARD TABLETS
🇺🇬UgandaNTICALS LTD.active
METOPROLOL SUCCINATE
ORAL SOLID RETARD FILM-COATED TABLETS
🇺🇬UgandaAJANTA PHARMA LIMITEDactive
METOPROLOL SUCCINATE
ORAL SOLID RETARD TABLETS
🇺🇬UgandaMEGA LIFESCIENCES PUBLIC COMPANY LTDactive

METOPROLOL SUCCINATE in Africa — Regulatory Overview

METOPROLOL SUCCINATE is registered across 4 African markets with 30 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Ghana, Kenya, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.

Of the 30 registrations, 30 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.